Skip to main content
. 2020 Aug 16;8(1):e001204. doi: 10.1136/bmjdrc-2020-001204

Table 1.

Baseline characteristics of 2444 black study participants by quintiles of mtDNA-CN, Atherosclerosis Risk in Communities study, 1987–1998

Mitochondrial DNA copy number quintiles
Overall Q1 Q2 Q3 Q4 Q5
Blacks (N) 2444 489 490 488 488 489
mtDNA-CN 0 (1) −1.48 (0.76) −0.39 (0.16) 0.09 (0.13) 0.55 (0.14) 1.25 (0.37)
Age, years 56.7 (6.0) 56.8 (6.1) 56.9 (6.1) 56.7 (5.9) 56.6 (5.9) 56.7 (5.9)
Female 64% (1554) 62% (308) 63% (310) 63% (311) 64% (315) 63% (310)
Center
 Forsyth County, North Carolina 12% (303) 11% (56) 14% (71) 11% (55) 13% (63) 12% (58)
 Jackson, Mississippi 88% (2163) 89% (438) 86% (422) 89% (438) 87% (430) 88% (435)
 Minneapolis, Minnesota
 Washington County, Maryland
Hypertension 59% (1460) 62% (305) 60% (295) 56% (277) 57% (282) 61% (301
Cardiovascular disease 11% (258) 15% (73) 10% (48) 10% (49) 8% (40) 10% (48)
Parental history of diabetes 22% (531) 23% (112) 20% (100) 21% (103) 21% (104) 23% (112)
Diabetes 23% (563) 23% (115) 20% (99) 23% (113) 24% (119) 24% (117)
BMI, kg/m2 30.1 (6.3) 30.0 (6.4) 29.5 (5.8) 30.6 (6.5) 30.2 (6.6) 30.1 (6.3)
High-risk waist-to-hip ratio
 Males (>0.90) 83% (761) 82% (153) 85% (155) 82% (149) 84% (149) 85% (155)
 Females (>0.85) 81% (1252) 82% (253) 80% (249) 83% (258) 78% (245) 80% (247)
HDL-C, mg/dL
 Male 49 (17.5) 51 (19.0) 46 (15.4) 49 (14.8) 50 (20.0) 49 (17.5)
 Female 56 (16.8) 55 (15.5) 57 (17.4) 56 (16.7) 56 (18.1) 55 (16.0)
Total cholesterol, mg/dL 211 (41.8) 210 (43.5) 210 (40.9) 210 (38.9) 212 (42.8) 214 (42.8)
LDL-C, mg/dL 134 (39.7) 133 (40.3) 134 (38.6) 133 (36.5) 134 (41.8) 137 (41.2)
Triglycerides, mg/dL 119 (76.5) 122 (99.9) 117 (73.2) 117 (72.3) 118 (67.2) 119.8 (64.7)
Smoking status
 Never 43% (1063) 39% (194) 42% (208) 46% (229) 45% (224) 42% (208)
 Former 29% (723) 30% (148) 28% (137) 30% (147) 28% (140) 31% (151)
 Current 27% (658) 30% (148) 29% (142) 23% (115) 25% (123) 26% (130)
Alcohol drinker
 Never 34% (840) 32% (160) 31% (154) 38% (187) 32% (158) 37% (181)
 Former 32% (787) 34% (169) 33% (162) 31% (151) 32% (157) 30% (148)
 Current 33% (817) 33% (161) 35% (172) 31% (153) 35% (172) 32% (159)
Hemoglobin A1C, % 6.4 (1.7) 6.4 (1.7) 6.3 (1.7) 6.4 (1.8) 6.3 (1.6) 6.4 (1.8)
Hemoglobin A1C, mmol/mol 46 (18.9) 46 (18.7) 45 (18.4) 46 (20.0) 46 (17.9) 47 (19.6)
Lactate, mmol/L† 9.5 (3.9) 9.8 (4.4) 9.2 (3.5) 9.4 (3.7) 9.9 (4.1) 9.4 (3.8)
Fasting glucose, mg/dL* 130 (66.8) 132 (70.6) 128 (68.3) 129 (67.6) 131 (66.5) 129 (61.1)
HOMA-IR, U 0.06 (0.03) 0.06 (0.14) 0.08 (0.15) 0.06 (0.08) 0.06 (0.08) 0.04 (0.03)
hs-CRP, mg/L† 6.1 (8.2) 5.6 (8.2) 6.4 (8.9) 6.2 (7.1) 6.5 (8.3) 5.9 (8.3)

Mean (SD) or % (N). Hypertension defined as diastolic blood pressure ≥90 mm Hg or systolic blood pressure ≥140 mm Hg or use of any antihypertensive medication in the past 2 weeks. Cardiovascular disease defined as self-reported history of stroke or coronary heart disease (previous myocardial infarction, coronary heart disease or ECG confirmation of previous myocardial infarction). Diabetes defined as self-report of doctor diagnosis, use of glucose-lowering medication, fasting blood glucose ≥126 mg/dL or non-fasting blood glucose ≥200 mg/dL. To convert lipids from mg/dL to mmol/L, divide by 38.67 for total cholesterol, HDL-C and LDL-C, and by 88.57 for triglycerides.

*Glucose (mg/dL)/405, with insulin measured at visit 1.

†Lactate measured at visit 4, n=259 blacks (224 without diabetes, 32 with diabetes) and n=390 whites (357 without diabetes, 32 with diabetes); CRP measured at visit 2, n=1838 blacks (1431 without diabetes, 392 with diabetes) and n=6914 whites (6356 without diabetes, 554 with diabetes).

BMI, body mass index; HDL-C, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment-estimated insulin resistance (insulin (U/L); hs-CRP, high-sensitivity C reactive protein; LDL-C, low-density lipoprotein cholesterol; mtDNA-CN, mitochondrial DNA copy number.